FDA Wins Toss Of Mallinckrodt Suit Over Equivalence Rating
A Maryland federal judge has axed Mallinckrodt Inc.'s lawsuit challenging a change to its therapeutic equivalence rating for a generic version of Janssen Pharmaceuticals Inc.'s Concerta, finding no procedural or constitutional...To view the full article, register now.
Already a subscriber? Click here to view full article